Journal
CLINICAL CASE REPORTS
Volume 6, Issue 12, Pages 2385-2390Publisher
WILEY
DOI: 10.1002/ccr3.1891
Keywords
biophotonic platform; chromophore; erythema; fluorescent light energy; inflammation; rosacea; subtype 1, 2, and 3
Categories
Ask authors/readers for more resources
Kleresca (R) biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca (R) may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available